- Home
- GORO vs HRTX Comparison
GORO vs HRTX Comparison
Compare GORO & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GORO | HRTX |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.5M | 228.3M |
| IPO Year | 2010 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GORO | HRTX |
|---|---|---|
| Price | $1.29 | $0.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.63 | ★ $4.50 |
| AVG Volume (30 Days) | 2.7M | ★ 3.5M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.80 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $99,759,000.00 | ★ $154,904,000.00 |
| Revenue This Year | $25.99 | $15.28 |
| Revenue Next Year | $5.78 | $20.29 |
| P/E Ratio | $43.67 | ★ N/A |
| Revenue Growth | ★ 51.78 | 7.36 |
| 52 Week Low | $0.43 | $0.38 |
| 52 Week High | $1.87 | $2.19 |
Technical Indicators
Market Signals| Indicator | GORO | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.52 | 34.02 |
| Support Level | $1.22 | $0.38 |
| Resistance Level | $1.47 | $0.46 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 48.74 | 26.86 |
Price Performance
Historical ComparisonAbout GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Companies only operating segment with a production stage property. The Companies other reporting segment is Michigan, U.S.A., with an exploration stage property.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.